DK161152C - Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat - Google Patents

Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat

Info

Publication number
DK161152C
DK161152C DK098884A DK98884A DK161152C DK 161152 C DK161152 C DK 161152C DK 098884 A DK098884 A DK 098884A DK 98884 A DK98884 A DK 98884A DK 161152 C DK161152 C DK 161152C
Authority
DK
Denmark
Prior art keywords
polypeptide
preparation
dna
vector
growth factor
Prior art date
Application number
DK098884A
Other languages
English (en)
Other versions
DK98884A (da
DK161152B (da
DK98884D0 (da
Inventor
Alane Molly Gray
Axel Ullrich
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23873671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK161152(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK98884D0 publication Critical patent/DK98884D0/da
Publication of DK98884A publication Critical patent/DK98884A/da
Publication of DK161152B publication Critical patent/DK161152B/da
Application granted granted Critical
Publication of DK161152C publication Critical patent/DK161152C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK098884A 1983-03-03 1984-02-24 Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat DK161152C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47196283A 1983-03-03 1983-03-03
US47196283 1983-03-03

Publications (4)

Publication Number Publication Date
DK98884D0 DK98884D0 (da) 1984-02-24
DK98884A DK98884A (da) 1984-10-04
DK161152B DK161152B (da) 1991-06-03
DK161152C true DK161152C (da) 1991-11-11

Family

ID=23873671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK098884A DK161152C (da) 1983-03-03 1984-02-24 Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat

Country Status (12)

Country Link
EP (1) EP0121338B2 (da)
JP (4) JPS6084299A (da)
KR (1) KR840008026A (da)
AT (1) ATE45382T1 (da)
AU (1) AU574350B2 (da)
CA (1) CA1220736A (da)
DE (1) DE3479321D1 (da)
DK (1) DK161152C (da)
ES (1) ES530202A0 (da)
IE (1) IE57013B1 (da)
NZ (1) NZ207337A (da)
ZA (1) ZA841597B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689845T3 (de) * 1985-09-12 2001-11-15 Scios Inc., Sunnyvale Rekombinanter fibroblast-wachstumsfaktor.
JPH01102096A (ja) * 1987-10-15 1989-04-19 Sanwa Kagaku Kenkyusho Co Ltd モチリン様活性を有するポリペプチド、その発現用微生物及び該ポリペプチドの製法
JPH01211490A (ja) * 1988-02-19 1989-08-24 Tosoh Corp ヒト神経成長因子遺伝子セグメント
IT1219874B (it) * 1988-03-18 1990-05-24 Fidia Farmaceutici Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche
US5134121A (en) * 1988-03-28 1992-07-28 Regents Of The University Of California Nerve growth factor peptides
US5683894A (en) * 1988-04-29 1997-11-04 University Of California Recombinant nerve growth factor
JPH0771509B2 (ja) * 1988-07-12 1995-08-02 工業技術院長 ヒトβ−ＮＧＦの発現法
US5082774A (en) * 1988-08-30 1992-01-21 The General Hospital Corporation Recombinant human nerve growth factor
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
US6709837B1 (en) * 1989-03-10 2004-03-23 Takeda Chemical Industries, Inc. Polypeptide and production thereof
SE8901715L (sv) * 1989-05-12 1990-11-13 Lope Medicine Ab En plasmid dna-konstruktion innehaallande dna-sekvenser
IT1232157B (it) * 1989-07-20 1992-01-25 Fidia Farmaceutici Purificazione del fattore di crescita nervoso tramite cromatografia a scambio di subunita'
DK0414151T3 (da) * 1989-08-21 1995-05-22 Takeda Chemical Industries Ltd Humane nervevæskstfaktorproteiner og fremstilling deraf
US5656435A (en) * 1989-08-28 1997-08-12 Takeda Chemical Industries, Ltd. Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof
IL95511A (en) * 1989-08-30 2000-10-31 Max Planck Gesellschaft Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor
US6933276B1 (en) 1989-08-30 2005-08-23 Regeneron Pharmaceuticals, Inc. Methods of treating peripheral neuropathies using neurotrophin-3
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
IT1238348B (it) * 1989-11-16 1993-07-13 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
JPH03244385A (ja) * 1990-02-21 1991-10-31 Hitachi Ltd ヒト神経成長因子の遺伝子工学的生産方法
IT1239271B (it) * 1990-02-27 1993-10-01 Fidia Spa Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante
US5986070A (en) * 1990-04-06 1999-11-16 Amgen Inc. Production of biologically active NGF proteins
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
PT100580A (pt) * 1991-06-12 1993-09-30 Regeneron Pharma Producao e recuperacao de neurotrofinas recombinantes
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
DE4139000A1 (de) * 1991-11-27 1993-06-03 Boehringer Mannheim Gmbh Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf
US6063757A (en) * 1995-11-29 2000-05-16 Urso; Richard G. Wound treatment method with nerve growth factor
JP4108755B2 (ja) * 1996-09-11 2008-06-25 大日本住友製薬株式会社 新規セマフォリン遺伝子：セマフォリンｙ
CA2268747A1 (en) 1996-11-15 1998-05-22 Genentech, Inc. Purification of neurotrophins
WO1998035027A2 (en) * 1997-02-06 1998-08-13 Hoechst Marion Roussel, Inc. Human nerve growth factor exon 1 and exon 3 promoters
US6197551B1 (en) * 1998-01-27 2001-03-06 Millennium Pharmaceuticals, Inc. Spoil-1 protein and nucleic acid molecules and uses therefor
ITRM20050045A1 (it) * 2005-02-02 2006-08-03 Consiglio Nazionale Ricerche Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi.
US7378359B2 (en) 2005-09-27 2008-05-27 Eleazer Howell B Moldable fibrous construction incorporating non-woven layers
US7300691B2 (en) 2005-09-27 2007-11-27 Milliken & Company Moldable construction incorporating non-olefin bonding interface
US7294384B2 (en) 2005-09-27 2007-11-13 Milliken & Company Moldable construction incorporating bonding interface
US20080124513A1 (en) 2006-09-11 2008-05-29 Eleazer Howell B Moldable fabric with unidirectional tape yarns
JP6767688B2 (ja) 2015-05-20 2020-10-14 パナソニックＩｐマネジメント株式会社 室内空調システム
IT202000005542A1 (it) 2020-03-16 2021-09-16 Themis S R L Metodo cosmetico per il trattamento della pelle e per la ricrescita dei capelli

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185095A (en) * 1977-11-23 1980-01-22 The Massachusetts General Hospital Nerve growth factor
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator

Also Published As

Publication number Publication date
JPS6084299A (ja) 1985-05-13
IE840493L (en) 1984-09-03
ZA841597B (en) 1984-10-31
ES8600783A1 (es) 1985-11-01
EP0121338B2 (en) 1999-10-27
JPH05310792A (ja) 1993-11-22
AU2525284A (en) 1984-09-06
NZ207337A (en) 1987-11-27
JP2740417B2 (ja) 1998-04-15
JPH067169A (ja) 1994-01-18
CA1220736A (en) 1987-04-21
ATE45382T1 (de) 1989-08-15
DK98884A (da) 1984-10-04
KR840008026A (ko) 1984-12-12
DK161152B (da) 1991-06-03
EP0121338A1 (en) 1984-10-10
JPH0536031B2 (da) 1993-05-28
EP0121338B1 (en) 1989-08-09
DK98884D0 (da) 1984-02-24
ES530202A0 (es) 1985-11-01
DE3479321D1 (en) 1989-09-14
JP2898494B2 (ja) 1999-06-02
IE57013B1 (en) 1992-03-11
JPH0690764A (ja) 1994-04-05
AU574350B2 (en) 1988-07-07

Similar Documents

Publication Publication Date Title
DK161152C (da) Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
DK460882A (da) Dna-sekvens, der koder for humant immun-interferon, replicerbareudtrykkelsesmedier herfor, mikroorganisme- eller cellekulturer transformeret med saadanne og fremgangsmaade til fremstilling af et polypeptid, der omfatter aminosyresekvensen af humant immun-interferon
DK144695A (da) Ekspressionsvektor eller et par af ekspressionsvektorer omfattende heterolog DNA, som koder for alfa- og beta-underenhederne af humant FSH, eukatyotisk celle transficeret med vektoren eller parret af vektorer, fremgangsmåde til fremstilling af biologisk aktivt heterodimert humant FSH og fremgangsmåde til fremstilling af et farmaceutisk præparat indeholdende rekombinant humant FSH
ES549539A0 (es) Un metodo para la preparacion de eritropoyetina.
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
DK13788A (da) Fremgangsmaade til fremstilling af et polypeptid
UA27706C2 (uk) Спосіб одержання гетерологічного поліпептиду
NO2007008I2 (no) Analoger av humant erytropoietin,DNA-sekvenser somkoder for disse, eukaryot vertscelle transfektert med DNA-sekvensene, preparat som omfatter analoge ne, anvendelse av analogene til økning av hematokritt, og fremgangsmåte for fremstilling av analogene.
DK268882A (da) Fremgangsmaade til fremstilling af et polypeptid, dna-sekvens, som koder for polypeptidet, replicerbart mikrobielt udtrykkelsesmedium, som i en transformant-mikroorganisme er i stand til at udtrykke polypeptidet og kultur af en mikroorganisme transformeret dermed
DK111183A (da) Polypeptid omfattende aminosyresekvensen af et dyreinterferon, dna-sekvens, der koder for polypeptidet, replicerbart udtrykkelsesmedium, som kan udtrykke dna-sekvensen, og fremgangsmaade til fremstilling af polypeptidet
DK165750C (da) Fremgangsmaade til fremstilling af humant gamma-interferonlignende polypeptid, polydeoxyribonucleotid, der koder for polypeptidet, plasmid indeholdende polydeoxyribonucleotidet samt en vaert for dette plasmid
ATE92961T1 (de) Dns-sequenz.
DK524287A (da) Fremgangsmaade til fremstilling af et polypeptid eller protein i hoej maengde i en transformeret vaertscelle
FI882238A0 (fi) Foerbaettringar i samband med organiska foereningar
DK171825B1 (da) DNA, som koder for human protein S herunder et polypeptid med human protein S-aktivitet, DNA-vektorer, værtsceller herunder cellekulturer, som er transformeret med disse vektorer, fremgangsmåde til fremstilling af human protein S, humant protein S fremstillet ved fremgangsmåden samt farmaceutisk middel, der består af humant protein S
NO873751L (no) Lymfocytt-aktiverende polypeptider.

Legal Events

Date Code Title Description
PUP Patent expired